Global Vaccine Raw Material Demand is Rapidly Growing | Top Companies statistics, Emerging Trends, Supply and Demand, Country wise Opportunity and Research Report to 2021, Says Brandessence Market Research

Our Bureau

PUNE– Brandessence Market Research has published a new report title” Global Vaccine Raw Material Market Size By Applications (Covid-19, Smallpox, Influenza, Measles, Mumps, Rubella, Polio, TB, Others), By End-User (Research Institute, Vaccine Manufacturers, Others) Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027″ Rising prevalence of various […]

Biopharmaceuticals Market to Reach USD 113,300 Million by 2026 at CAGR 4.7% – Valuates Reports

Our Bureau

The Biopharmaceuticals Market is Segmented by Type (Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin , Insulin, Vaccines, Growth Hormones, Others), by Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Others). The report covers global opportunity analysis and industry forecast from 2021 to 2026. It is published on Valuates Reports in the Pharmaceuticals & Biotech Category. Major factors driving the growth of the global biopharmaceuticals market […]

Glenmark’s Ryaltris® nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age

Our Bureau

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union. Ryaltris® (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), will shortly be available in Austria, Belgium, Czech […]

Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER

Our Bureau

PISCATAWAY, N.J: MSN Labs, based in Hyderabad, India, received FDA approval to market their generic versions of Albendazole 200mg tablets (AB rated to Albenza©), Droxidopa 100mg, 200mg, 300mg capsules (AB rated to Northera ©), Deferasirox Granules 180mg, 360mg sachets (AB rated to Jadenu Sprinkles©) and Pregabalin ER 82.5mg, 165mg, 330mg tablets, […]

CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth

Our Bureau

Amsterdam: Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity […]

USAID launches Cargill, Ausvet, Heifer International and IPC consortium to combat threat of IPC, antimicrobial resistance to human and animal health

Our Bureau

Washington: The  United States Agency for International Development (USAID) has tapped a consortium led by Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC) to improve livestock management and combat the threat of zoonotic diseases to both human and animal health. The five-year, $33 million Transformational Strategies for Farm Output Risk Mitigation […]

Skin-Deep Beauty with Microalgae Bioactive Ingredient

Our Bureau

Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector. This topically applied bioactive ingredient from the Porphyridium cruentum species of microalgae is in high demand by the cosmetics industry for its naturally tendering anti-aging, anti-inflammatory, and rejuvenating properties. The ingredient, branded EPS-Revive, […]

RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue

Our Bureau

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva®, ABC294640)[1] in patients hospitalized with severe COVID-19 pneumonia has received a unanimous recommendation to continue, following a fourth independent Data Safety Monitoring Board (DSMB) safety review. […]

Zentiva Continues Its Expansion In Oncology With The Launch Of ALYMSYS® (bevacizumab) In 21 Countries Across Europe

Our Bureau

Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific package which demonstrated biosimilarity of ALYMSYS® to the originator reference product. Nick Haggar, Chief Executive Officer of Zentiva stated: “We are […]

Subscribe Now